# OncoShield: Cancer Genomics Dual-Use Risk Tool

## ğŸš¨ Purpose

**OncoShield** is a secure, biosecurity-aware framework built for cancer researchers, hospitals, and biotech firms. It helps detect dual-use risks, synthetic constructs, or pipeline tampering in genomic workflows.

This tool addresses increasing concerns around misuse of cancer genomics dataâ€”particularly synthetic variants, engineered constructs, or manipulated diagnostic pipelines that could lead to misdiagnosis or biosecurity threats.

---

## ğŸ”¬ Core Functions

- **Synthetic Mutation Detection:** Identify known or engineered oncogenic patterns from COSMIC, Addgene, iGEM.
- **Secure Variant Calling:** Hardened variant-calling pipelines with cryptographic integrity and audit layers.
- **Red Team Module:** Simulate cancer mimicry, synthetic variant spiking, or malicious pipeline interventions.
- **Clinical Dashboard:** Highlight dual-use risk, pipeline tampering indicators, and diagnostic uncertainty.

---

## ğŸ‘¤ Target Users

- Academic cancer research groups
- Biotech & diagnostics companies
- Hospital molecular pathology labs
- Bioethics & biosecurity committees

---

## ğŸŒ Geographic Focus

- U.S. & EU clinical and research networks
- Global cancer genomics centers
- Prospective outreach to African cancer genomics projects

---

## ğŸ“š Data Sources (Phase 1)

- **COSMIC** â€“ Oncogenic mutation datasets
- **Addgene / iGEM** â€“ Synthetic biology constructs
- **TCGA** â€“ NGS pipelines, reference workflows

---

## ğŸ“… Current Phase

**Phase 1: MVP Initialization & Dataset Curation**
- Week 1: Project setup, data sourcing, integrity scaffolding
- Week 2: Pipeline prototyping and synthetic feature modeling

---

## âš ï¸ Security & Ethics

OncoShield is designed with biosecurity principles. Dataset handling and synthetic detection modules will follow strict ethical review and red-teaming protocols to prevent dual-use abuse.

---

## License

MIT License (TBD)
